|
|
positive regulation of necrotic cell death
|
GO:0010940 |
4 |
0.935
|
|
|
|
regulation of insulin secretion
|
GO:0050796 |
33 |
0.926
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.886
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.872
|
Human |
|
|
actin filament organization
|
GO:0007015 |
128 |
0.706
|
|
|
|
negative regulation of voltage gated calcium channel activity
|
GO:1901386 |
4 |
0.685
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.674
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.651
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.644
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.641
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.611
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.600
|
|
|
|
somatic stem cell division
|
GO:0048103 |
1 |
0.596
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.594
|
Human |
|
|
protein autoprocessing
|
GO:0016540 |
4 |
0.579
|
|
|
|
nuclear migration
|
GO:0007097 |
1 |
0.578
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.570
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.547
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.536
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.530
|
Human |
|
|
stem cell division
|
GO:0017145 |
2 |
0.521
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.514
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.513
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.498
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.493
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.484
|
|
|
|
glucose transport
|
GO:0015758 |
30 |
0.478
|
|
|
|
neuronal stem cell division
|
GO:0036445 |
1 |
0.476
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.473
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.466
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.454
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
50 |
0.453
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.449
|
|
|
|
anterograde axon cargo transport
|
GO:0008089 |
1 |
0.447
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.443
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.439
|
|
|
|
establishment of nucleus localization
|
GO:0040023 |
1 |
0.432
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.430
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.415
|
|
|
|
protein glycosylation
|
GO:0006486 |
62 |
0.403
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.390
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.386
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.385
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.375
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.372
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.368
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
62 |
0.366
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.364
|
Human |
|
|
post embryonic development
|
GO:0009791 |
2 |
0.360
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.346
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.337
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.331
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.330
|
Human |
|
|
peptide transport
|
GO:0015833 |
74 |
0.329
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.319
|
|
|
|
regulation of necrotic cell death
|
GO:0010939 |
9 |
0.318
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
56 |
0.307
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.306
|
|
|
|
type b pancreatic cell apoptotic process
|
GO:0097050 |
5 |
0.305
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.301
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.300
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.298
|
|
|
|
positive regulation of glucose transport
|
GO:0010828 |
17 |
0.297
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.295
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.291
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.286
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.283
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
15 |
0.283
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.280
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.279
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
10 |
0.278
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.263
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.262
|
|
|
|
protein polymerization
|
GO:0051258 |
71 |
0.261
|
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
2 |
0.255
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.251
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.251
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.241
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.239
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.226
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.226
|
|
|
|
cell projection assembly
|
GO:0030031 |
126 |
0.222
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.222
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.217
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.217
|
|
|
|
glucose import
|
GO:0046323 |
24 |
0.211
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
56 |
0.209
|
|
|
|
midbrain development
|
GO:0030901 |
45 |
0.206
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.202
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.196
|
|
|
|
actin filament polymerization
|
GO:0030041 |
45 |
0.194
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.191
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.190
|
|
|
|
insulin secretion
|
GO:0030073 |
39 |
0.173
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.170
|
Human |
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.168
|
Human |
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.168
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.166
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.164
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.163
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.162
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.162
|
|
|
|
neural nucleus development
|
GO:0048857 |
47 |
0.160
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.157
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.156
|
Human |
|
|
neuroblast division
|
GO:0055057 |
1 |
0.155
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.154
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
41 |
0.154
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.151
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.151
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.150
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
15 |
0.149
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.149
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.149
|
|
|
|
thiamine transmembrane transport
|
GO:0071934 |
2 |
0.149
|
|
|
|
negative regulation of protein sumoylation
|
GO:0033234 |
5 |
0.147
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.146
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.146
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.146
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
25 |
0.146
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.143
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.141
|
Human |
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.139
|
|
|
|
head development
|
GO:0060322 |
108 |
0.137
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.136
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.134
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.134
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.131
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.131
|
|
|
|
negative regulation of protein modification by small protein conjugation or removal
|
GO:1903321 |
41 |
0.130
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
56 |
0.130
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
33 |
0.129
|
Human |
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.126
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.126
|
Human |
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
72 |
0.125
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.125
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.124
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.124
|
|
|
|
cellular response to peptide
|
GO:1901653 |
59 |
0.123
|
|
|
|
nucleus localization
|
GO:0051647 |
1 |
0.122
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.120
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.120
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.119
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
7 |
0.116
|
Human |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.116
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.114
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.113
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.112
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.112
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.110
|
|
|
|
hexose transport
|
GO:0008645 |
30 |
0.110
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.108
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.107
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
59 |
0.107
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.107
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.105
|
|
|
|
system process
|
GO:0003008 |
349 |
0.104
|
Human |
|
|
hemostasis
|
GO:0007599 |
76 |
0.103
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.099
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.098
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.098
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
79 |
0.097
|
Human |
|
|
carbohydrate transport
|
GO:0008643 |
37 |
0.094
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.094
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.094
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.093
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.092
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.092
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.091
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
31 |
0.091
|
|
|
|
regulation of glucose transport
|
GO:0010827 |
23 |
0.090
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.090
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.089
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.089
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.088
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
47 |
0.088
|
|
|
|
single fertilization
|
GO:0007338 |
11 |
0.087
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.086
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.084
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.084
|
|
|
|
transposition rna mediated
|
GO:0032197 |
0 |
0.084
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.083
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.082
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.082
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.082
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.081
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.079
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.077
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.077
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.076
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
56 |
0.075
|
|
|
|
regulation of glucose import
|
GO:0046324 |
21 |
0.075
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.074
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.074
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.074
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.074
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.073
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.073
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.073
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.073
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.073
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.072
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
42 |
0.072
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.072
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.071
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.070
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.070
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.070
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.070
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.070
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.069
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.069
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.068
|
Human |
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.068
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.068
|
|
|
|
negative regulation of ion transmembrane transport
|
GO:0034766 |
26 |
0.067
|
Human |
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
2 |
0.067
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.066
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.065
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.065
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.064
|
|
|
|
protein sumoylation
|
GO:0016925 |
25 |
0.064
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.063
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.063
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.063
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.063
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
76 |
0.063
|
Human |
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.062
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.062
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.061
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.061
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.060
|
Human |
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.059
|
|
|
|
negative regulation of phosphatase activity
|
GO:0010923 |
61 |
0.058
|
|
|
|
monosaccharide transport
|
GO:0015749 |
32 |
0.058
|
|
|
|
negative regulation of transmembrane transport
|
GO:0034763 |
29 |
0.058
|
Human |
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.058
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.057
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.057
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.057
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.056
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.056
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
75 |
0.056
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.055
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
3 |
0.055
|
|
|
|
regulation of protein polymerization
|
GO:0032271 |
63 |
0.055
|
|
|
|
protein stabilization
|
GO:0050821 |
64 |
0.053
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.053
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.052
|
Human |
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.052
|
Human |
|
|
regulation of protein sumoylation
|
GO:0033233 |
13 |
0.051
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.050
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.050
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.050
|
|
|
|
response to insulin
|
GO:0032868 |
45 |
0.050
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.049
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.049
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
73 |
0.048
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.048
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
42 |
0.048
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.047
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.047
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.046
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.046
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.045
|
|
|
|
substantia nigra development
|
GO:0021762 |
45 |
0.045
|
|
|
|
platelet aggregation
|
GO:0070527 |
32 |
0.045
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.045
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.044
|
|
|
|
establishment of mitotic spindle orientation
|
GO:0000132 |
7 |
0.044
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.044
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.044
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.044
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.043
|
Human |
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.042
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
72 |
0.042
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
73 |
0.042
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.041
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.041
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.041
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
78 |
0.041
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
36 |
0.040
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.040
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.040
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
91 |
0.040
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.039
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.039
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.039
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.038
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.038
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.038
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
37 |
0.038
|
|
|
|
ruffle organization
|
GO:0031529 |
18 |
0.038
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.037
|
Human |
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.037
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.037
|
|
|
|
positive regulation of actin filament polymerization
|
GO:0030838 |
38 |
0.037
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.036
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.036
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.035
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.035
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.035
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.035
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.035
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.035
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
63 |
0.035
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.035
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.034
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.034
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.034
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.034
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.034
|
|
|
|
cortical cytoskeleton organization
|
GO:0030865 |
9 |
0.033
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.033
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.033
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.033
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.033
|
|
|
|
actin filament bundle organization
|
GO:0061572 |
54 |
0.033
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.033
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.033
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.033
|
|
|
|
regulation of transposition
|
GO:0010528 |
7 |
0.032
|
|
|
|
establishment of cell polarity
|
GO:0030010 |
22 |
0.032
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.032
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.032
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.032
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.032
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.032
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.032
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.031
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.031
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.031
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
15 |
0.031
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.031
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.030
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.030
|
|
|
|
regulation of meiosis
|
GO:0040020 |
3 |
0.030
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.030
|
|
|
|
hair cell differentiation
|
GO:0035315 |
2 |
0.030
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.030
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.029
|
|
|
|
regulation of neurotransmitter secretion
|
GO:0046928 |
3 |
0.029
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.029
|
|
|
|
renal tubule development
|
GO:0061326 |
19 |
0.029
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.029
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.029
|
|
|
|
growth
|
GO:0040007 |
202 |
0.029
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.028
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.028
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.028
|
|
|
|
thiamine transport
|
GO:0015888 |
3 |
0.028
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.028
|
|
|
|
positive regulation of lipase activity
|
GO:0060193 |
28 |
0.028
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.028
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.028
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.027
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
54 |
0.027
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.027
|
Human |
|
|
platelet activation
|
GO:0030168 |
44 |
0.027
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
2 |
0.027
|
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.027
|
|
|
|
response to amino acid
|
GO:0043200 |
14 |
0.026
|
|
|
|
negative regulation of cation channel activity
|
GO:2001258 |
12 |
0.026
|
Human |
|
|
negative regulation of stress activated mapk cascade
|
GO:0032873 |
19 |
0.026
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.026
|
|
|
|
copper ion homeostasis
|
GO:0055070 |
3 |
0.026
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.026
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.026
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.026
|
|
|
|
regulation of actin filament depolymerization
|
GO:0030834 |
10 |
0.026
|
|
|
|
pyrimidine containing compound transmembrane transport
|
GO:0072531 |
4 |
0.025
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.025
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.025
|
|
|
|
ectodermal placode development
|
GO:0071696 |
1 |
0.025
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.025
|
|
|
|
single organism carbohydrate catabolic process
|
GO:0044724 |
33 |
0.025
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.025
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.025
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.025
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.025
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.025
|
|
|
|
negative regulation of calcium ion transmembrane transporter activity
|
GO:1901020 |
11 |
0.025
|
Human |
|
|
vacuole organization
|
GO:0007033 |
44 |
0.024
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.024
|
|
|
|
fertilization
|
GO:0009566 |
12 |
0.024
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.024
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.024
|
|
|
|
regulation of dephosphorylation
|
GO:0035303 |
96 |
0.024
|
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
45 |
0.024
|
|
|
|
somatic muscle development
|
GO:0007525 |
1 |
0.024
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
47 |
0.024
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.024
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.024
|
|
|
|
vesicle organization
|
GO:0016050 |
62 |
0.024
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.024
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.023
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.023
|
|
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.023
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.023
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
60 |
0.023
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.022
|
|
|
|
establishment or maintenance of epithelial cell apical basal polarity
|
GO:0045197 |
1 |
0.022
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.022
|
|
|
|
myosin filament organization
|
GO:0031033 |
2 |
0.022
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.022
|
Human |
|
|
cortical actin cytoskeleton organization
|
GO:0030866 |
9 |
0.022
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.022
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.022
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.022
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.022
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
4 |
0.022
|
|
|
|
activation of phospholipase d activity
|
GO:0031584 |
3 |
0.022
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.022
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.022
|
|
|
|
negative regulation of ion transmembrane transporter activity
|
GO:0032413 |
19 |
0.021
|
Human |
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.021
|
|
|
|
multicellular organism reproduction
|
GO:0032504 |
42 |
0.021
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.021
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.021
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.021
|
Human |
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.021
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.021
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.021
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.021
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.021
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.021
|
|
|
|
axon cargo transport
|
GO:0008088 |
2 |
0.021
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
84 |
0.021
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
74 |
0.020
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.020
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.020
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.020
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
1 |
0.020
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.020
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.020
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.020
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.020
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.020
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.020
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.019
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.019
|
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.019
|
|
|
|
adenylate cyclase activating adrenergic receptor signaling pathway
|
GO:0071880 |
3 |
0.019
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.019
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.019
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.019
|
|
|
|
ectodermal placode formation
|
GO:0060788 |
1 |
0.019
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.019
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.019
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
3 |
0.018
|
|
|
|
receptor catabolic process
|
GO:0032801 |
11 |
0.018
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.018
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.018
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
20 |
0.018
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.018
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.018
|
|
|
|
aging
|
GO:0007568 |
66 |
0.018
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.018
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.018
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.018
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.018
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
3 |
0.018
|
|
|
|
regulation of methylation dependent chromatin silencing
|
GO:0090308 |
3 |
0.018
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.018
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.018
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.018
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.018
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.018
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.018
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.017
|
Human |
|
|
multicellular organismal signaling
|
GO:0035637 |
34 |
0.017
|
Human |
|
|
response to reactive oxygen species
|
GO:0000302 |
61 |
0.017
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.017
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
56 |
0.017
|
|
|
|
regulation of phosphatase activity
|
GO:0010921 |
81 |
0.017
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
40 |
0.017
|
|
|
|
negative regulation of protein complex assembly
|
GO:0031333 |
43 |
0.017
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.017
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.017
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.017
|
|
|
|
positive regulation of protein polymerization
|
GO:0032273 |
45 |
0.017
|
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
21 |
0.017
|
|
|
|
regulation of glial cell proliferation
|
GO:0060251 |
4 |
0.017
|
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.017
|
|
|
|
protein depolymerization
|
GO:0051261 |
30 |
0.017
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.017
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.016
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
23 |
0.016
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
50 |
0.016
|
|
|
|
barbed end actin filament capping
|
GO:0051016 |
3 |
0.016
|
|
|
|
necrotic cell death
|
GO:0070265 |
21 |
0.016
|
|
